Abstract
ejd.2013.2123 Auteur(s) : Akira Tuskada, Taku Fujimura tfujimura1@mac.com, Akira Hashimoto, Yumi Kambayashi, Sadanori Furudate, Takahiro Haga, Setsuya Aiba Department of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai, 980-8574, Japan Merkel cell carcinoma is an aggressive, cutaneous, neuroendocrine carcinoma [1]. The outcome remains poor for patients with metastatic disease, with a median survival of only 10 months [1]. The conventional therapy for [...]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
